Pura Vida Investments’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49,159	Closed	-$370K	–	145
2022 Q1	$370K	Buy	49,159 +275	+0.6%	+$2.07K	0.01%	101
2021 Q4	$440K	Buy	+48,884	New	+$440K	0.02%	122